Hypoxia and the extracellular matrix: drivers of tumour metastasis
Open accessThe DOI matches its Crossref record; 209 of the 209 references it cites were found in a registry or an index.
Abstract
Of the deaths attributed to cancer, 90% are due to metastasis, and treatments that prevent or cure metastasis remain elusive. Emerging data indicate that hypoxia and the extracellular matrix (ECM) might have crucial roles in metastasis. During tumour evolution, changes in the composition and the overall content of the ECM reflect both its biophysical and biological properties and these strongly influence tumour and stromal cell properties, such as proliferation and motility. Originally thought of as independent contributors to metastatic spread, recent studies have established a direct link between hypoxia and the composition and the organization of the ECM, which suggests a new model in which multiple microenvironmental signals might converge to synergistically influence metastatic outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, secretion of hypoxia-inducible factors (HIFs) by tumor cells induces macrophage and fi broblast recruitment to hypoxic regions of the primary tumor, leading to increased ECM remodeling and angiogenesis [21].”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In vivo, stromal cells such as fibroblasts and endothelial cells do not remain statically embedded but actively reposition themselves in response to gradients in oxygen, nutrients, and soluble factors [274,275].”
From Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis (2025) · cites this paper as [274]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“recently published literature discusses the role of the size of a tumor (and the associated hypoxia levels) on its aggressiveness [81,82,83,84,85] and on the efficacy of drug delivery to it [84,86,87].”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [83]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
6 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
RetractedGilkes, D. M., Bajpai, S., Chaturvedi, P., Wirtz, D., & Semenza, G. L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.442939 · Cited by 467
Self-citationRetractedZhang, H., Wong, C. C. L., Wei, H., Gilkes, D. M., Korangath, P., Chaturvedi, P., Schito, L., Chen, J., Krishnamachary, B., Winnard, P. T., et al. (2012) · Oncogene · doi:10.1038/onc.2011.365 · Cited by 326
Self-citationRetractedRETRACTED: Collagen Prolyl Hydroxylases Are Essential for Breast Cancer Metastasis
Gilkes, D. M., Chaturvedi, P., Bajpai, S., Wong, C. C., Wei, H., Pitcairn, S., Hubbi, M. E., Wirtz, D., & Semenza, G. L. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3963 · Cited by 296
Self-citationRetractedProcollagen lysyl hydroxylase 2 is essential for hypoxia-induced breast cancer metastasis
Gilkes, D. M., Bajpai, S., Wong, C. C., Chaturvedi, P., Hubbi, M. E., Wirtz, D., & Semenza, G. L. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0629 · Cited by 252
Self-citationRetractedGilkes, D. M., Xiang, L., Lee, S. J., Chaturvedi, P., Hubbi, M. E., Wirtz, D., & Semenza, G. L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321510111 · Cited by 184
Self-citationRetractedMolecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Self-citationWang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Self-citationThe tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Cited by
Items 501–600 of 1,001
Fu, Y., Guo, X., Sun, L., Cui, T., Wu, C., Wang, J., Liu, Y., & Liu, L. (2024) · eLife · doi:10.7554/elife.95009 · Cited by 39
“Moreover, the hypoxic TME regulates ECM remodeling by CAFs, with HIF-1 α -expressing CAFs promoting tumorigenesis and metastasis ( Calvo et al., 2013 ; Gilkes et al., 2014 ).”
BackgroundDai, H., Zhang, X., Zhao, Y., Nie, J., Hang, Z., Huang, X., Ma, H., Wang, L., Li, Z., Wu, M., et al. (2025) · Hereditas · doi:10.1186/s41065-025-00409-4 · Cited by 33
“Perturbations in ECM levels can directly alter its biological attributes, thereby fostering cancer dissemination via tumor cell heterogeneity [68].”
Maroni, P., Matteucci, E., Drago, L., Banfi, G., Bendinelli, P., & Desiderio, M. A. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.10.004 · Cited by 35
RetractedZhang, L., Wang, Y., Xia, T., Yu, Q., Zhang, Q., Yang, Y., Cun, X., Lu, L., Gao, H., Zhang, Z., et al. (2016) · Drug Delivery · doi:10.3109/10717544.2015.1132798 · Cited by 32
Noncoding RNAs in Tumor Epithelial‐to‐Mesenchymal Transition
Lin, C.-W., Lin, P.-Y., & Yang, P. (2016) · Stem Cells International · doi:10.1155/2016/2732705 · Cited by 35
Anticancer effects of morin-7-sulphate sodium, a flavonoid derivative, in mouse melanoma cells
Li, H.-W., Zou, T., Jia, Q., Xia, E.-Q., Cao, W.-J., Liu, W., He, T., & Wang, Q. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.10.001 · Cited by 34
Dumas, J., Brisson, L., Chevalier, S., Mahéo, K., Fromont, G., Moussata, D., Besson, P., & Roger, S. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.03.004 · Cited by 34
Chang, T.-Y., Chen, C., Lee, M., Chang, Y., Lu, C.-H., Lu, S.-T., Wang, D.-Y., Wang, A., Guo, C., & Cheng, P. (2017) · eLife · doi:10.7554/elife.31101 · Cited by 31
Farré, N., Otero, J., Falcones, B., Torres, M., Jorba, I., Gozal, D., Almendros, I., Farré, R., & Navajas, D. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01143 · Cited by 36
Wu, Y. C., Wei, J., Chen, X., Qin, Y., Mao, R., Song, J., & Fan, Y. (2018) · International Journal of Cancer · doi:10.1002/ijc.31875 · Cited by 34
Stress responses in stromal cells and tumor homeostasis
Vitale, I., Manic, G., Galassi, C., & Galluzzi, L. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.04.004 · Cited by 34
Wang, X., Cheng, X., He, L., Zeng, X., Zheng, Y., & Tang, R. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b05855 · Cited by 32
Bhat, V., Allan, A. L., & Raouf, A. (2019) · Cancers · doi:10.3390/cancers11091240 · Cited by 36
Hypoxic Jumbo Spheroids On-A-Chip (HOnAChip): Insights into Treatment Efficacy
Refet-Mollof, E., Najyb, O., Chermat, R., Glory, A., Lafontaine, J., Wong, P., & Gervais, T. (2021) · Cancers · doi:10.3390/cancers13164046 · Cited by 36
HIF-Dependent Mechanisms of Relationship between Hypoxia Tolerance and Tumor Development
Dzhalilova, D. S., & Makarova, O. V. (2021) · Biochemistry (Moscow) · doi:10.1134/s0006297921100011 · Cited by 39
STAT3/HIF-1α/fascin-1 axis promotes RA FLSs migration and invasion ability under hypoxia
Wang, Y., Wei, X., Jiao, Y., Bai, Y., Sam, W. N., Yan, Q., Sun, X., Li, G., Ma, J., Wei, W., et al. (2021) · Molecular Immunology · doi:10.1016/j.molimm.2021.12.004 · Cited by 33
Triboelectric Current Stimulation Alleviates In Vitro Cell Migration And In Vivotumor Metastasis
Chu, B., Qin, X., Zhu, Q., Wang, H., Wen, Z., Sun, X., He, Y., & Lee, S. (2022) · Nano Energy · doi:10.1016/j.nanoen.2022.107471 · Cited by 33
Jeong, S. H., Son, E. S., Lee, Y. E., Kyung, S. Y., Park, J.-W., & Kim, S. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00796-y · Cited by 36
Nanotechnological strategies to increase the oxygen content of the tumor
Zhang, J., Tang, K., Fang, R., Liu, J., Liu, M., Ma, J., Wang, H., Ding, M., Wang, X., Song, Y., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1140362 · Cited by 39
“Hypoxia causes a reduction in the enzyme activity of prolyl hydroxylase and prevents HIF-1α hydroxylation, which is the master transcriptional regulator in cells under hypoxic conditions (Gilkes et al., 2014; Rankin andGiaccia, 2016b; Jing et al., 2019; Singleton et al., 2021).”
BackgroundLiu, T., Wan, X., Chen, Z., Wang, G., Cao, R., Zhou, F., Meng, Z., Luo, Y., & Chen, L. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06298-7 · Cited by 41
Review of possible mechanisms of radiotherapy resistance in cervical cancer
Zhang, H., Wang, X., Ma, Y., Zhang, Q., Liu, R., Luo, H., & Wang, Z. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1164985 · Cited by 37
Zhu, D., Lu, Y., Yang, S., Hu, T., Tan, C., Liang, R., & Wang, Y. (2024) · Advanced Science · doi:10.1002/advs.202401064 · Cited by 35
Yu, H., Du, Y., He, Y., Sun, Y., Li, J., Jia, B., Chen, J., Peng, X., An, T., Li, J., et al. (2025) · Cell Host & Microbe · doi:10.1016/j.chom.2025.06.013 · Cited by 36
Gregorio, V. D., Imparato, G., Urciuolo, F., Tornesello, M. L., Annunziata, C., Buonaguro, F. M., & Netti, P. A. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201601199 · Cited by 31
Završnik, J., Butinar, M., Prebanda, M. T., Krajnc, A., Vidmar, R., Fonovič, M., GRUBB, A. O., Türk, V., Turk, B., & Vasiljeva, O. S. (2017) · Oncotarget · doi:10.18632/oncotarget.17379 · Cited by 35
Labrousse-Arias, D., Martínez-Ruiz, A., & Calzada, M. J. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7275 · Cited by 30
Identification of Ppar γ -modulated miRNA hubs that target the fibrotic tumor microenvironment
Winkler, I., Bitter, C., Winkler, S., Weichenhan, D., Thavamani, A., Hengstler, J. G., Borkham‐Kamphorst, E., Kohlbacher, O., Plass, C., Geffers, R., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1909145117 · Cited by 36
“Collagens represent the most abundant ECM component and collagen I deposition has been associated with increased incidence of tumor formation and metastasis (21).”
BackgroundFerreira, F., Luxardi, G., Reid, B., Ma, L., Raghunathan, V. K., & Zhao, M. (2020) · Nature Protocols · doi:10.1038/s41596-019-0231-x · Cited by 32
Dash, B. C., Setia, O., Gorecka, J., Peyvandi, H., Duan, K., Lopes, L. L. N. M., Nie, J., Berthiaume, F., Dardik, A., & Hsia, H. C. (2020) · Cells · doi:10.3390/cells9040966 · Cited by 32
Prognostic and immunological role of Fam20C in pan-cancer
Liu, X., Zhan, Y., Xu, W., Liu, X., Geng, Y., Liu, L., Da, J., Wang, J., Zhang, X., jin, H., et al. (2020) · Bioscience Reports · doi:10.1042/bsr20201920 · Cited by 35
Luo, R., Zhang, Z., Han, L., Xue, Z. H., Zhang, K., Liu, F., Feng, F., Xue, J., Liu, W., & Qu, W. (2021) · Biomaterials Science · doi:10.1039/d1bm00284h · Cited by 32
Sun, X., Luo, H., Chenbo, H., Zhang, Y., & Yan, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.700062 · Cited by 37
Portal vein tumor thrombosis in hepatocellular carcinoma: molecular mechanism and therapy
Zhou, X.-H., Li, J., Zheng, T., Chen, H., Cai, C., Ye, S., Gao, B., & Xue, T. (2022) · Clinical & Experimental Metastasis · doi:10.1007/s10585-022-10188-1 · Cited by 35
Zhang, Z., Li, W., Liu, Y., Fang, X., & Wu, C. (2022) · Advanced Optical Materials · doi:10.1002/adom.202202052 · Cited by 32
The Study of the Extracellular Matrix in Chronic Inflammation: A Way to Prevent Cancer Initiation?
Marangio, A., Biccari, A., D’Angelo, E., Sensi, F., Spolverato, G., Pucciarelli, S., & Agostini, M. (2022) · Cancers · doi:10.3390/cancers14235903 · Cited by 37
“Neutrophils are attracted to the tumor site by the hypoxic condition [201] and active angiogenesisinducing MMP-9 [202], which, not being complexed with its inhibitor TIMP-1, has a stronger activity [69].”
BackgroundInfluentialExploring Heteroaryl-pyrazole Carboxylic Acids as Human Carbonic Anhydrase XII Inhibitors
Cadoni, R., Pala, N., Lomelino, C. L., Mahon, B. P., McKENNA, R. V., Dallocchio, R. N., Dessì, A., Carcelli, M., Rogolino, D., Sanna, V., et al. (2017) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.7b00229 · Cited by 31
Functional Imaging of Hypoxia: PET and MRI
Perez, R. C., Kim, D., Maxwell, A. W. P., & Camacho, J. C. (2023) · Cancers · doi:10.3390/cancers15133336 · Cited by 38
The Inhibition of Vessel Co-Option as an Emerging Strategy for Cancer Therapy
Carrera-Aguado, I., Marcos-Zazo, L., Carrancio-Salán, P., Guerra-Paes, E., Sánchez‐Juanes, F., & Muñoz‐Félix, J. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020921 · Cited by 32
“Moreover, the presence of CAFs and collagen I abundance in ECM promotes TGF-β liberation, which suppresses the immune system and increases collagen, fibronectin and proteoglycan abundance, promoting the migration and dissemination of cancer cells [149].”
BackgroundInfluentialPhotothermally Active Quantum Dots in Cancer Imaging and Therapeutics: Nanotheranostics Perspective
Debnath, M., Sarkar, S., Debnath, S. K., Dkhar, D. S., Kumari, R., Vaskuri, G. S. S. J., Srivastava, A., Chandra, P., Prasad, R., & Srivastava, R. (2024) · ACS Applied Bio Materials · doi:10.1021/acsabm.4c01190 · Cited by 32
Liu, Q., Yu, M., Lin, Z., Wu, L., Xia, P., Zhu, M., Huang, B., Wu, W., Zhang, R., Li, K., et al. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217731 · Cited by 41
Expressions of Collagen I and III in Hypoxic Keloid Tissue.
Wulandari, E., Jusman, S. W. A., Moenadjat, Y., Jusuf, A. A., & Sadikin, M. (2016) · Institutional Repositories DataBase (IRDB) · doi:10.24546/81009624 · Cited by 37
Chojnacka, K., & Lewandowska, U. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.05.001 · Cited by 31
OKUNO, T., Kawai, K., Hata, K., Murono, K., Emoto, S., Kaneko, M., Sasaki, K., Nishikawa, T., Tanaka, T., & Nozawa, H. (2018) · Anticancer Research · doi:10.21873/anticanres.12598 · Cited by 32
Efficacy of inverso isomer of CendR peptide on tumor tissue penetration
Wang, R., Shen, Q., Li, X., Xie, C., Lu, W., Wang, S., Wang, J., Wang, D., & Liu, M. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.06.006 · Cited by 30
Hypoxia Patterns in Primary and Metastatic Prostate Cancer Environments
Bharti, S. K., Kakkad, S. M., Danhier, P., Wildes, F. B., Penet, M., Krishnamachary, B., & Bhujwalla, Z. M. (2019) · Neoplasia · doi:10.1016/j.neo.2018.12.004 · Cited by 34
Zhang, J., Fu, B., Li, M., & Mi, S. (2020) · Small · doi:10.1002/smll.202004750 · Cited by 30
Synthetic promoters to induce immune-effectors into the tumor microenvironment
Greenshpan, Y., Sharabi, O., Ottolenghi, A., Cahana, A., Kundu, K., Yegodayev, K. M., Elkabets, M., Gazit, R., & Porgador, A. (2021) · Communications Biology · doi:10.1038/s42003-021-01664-7 · Cited by 32
Yi, X., Yan, Y., Li, L., Li, Q., Xiang, Y., & Huang, Y. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202010283 · Cited by 31
Applications of Polymers for Organ-on-Chip Technology in Urology
Gălățeanu, B., Hudiță, A., Bîru, E. I., Iovu, H., Zaharia, C., Simsensohn, E., Costache, M., Petca, R., & Jinga, V. (2022) · Polymers · doi:10.3390/polym14091668 · Cited by 32
Zhang, W., Hu, J., Liu, R., Dai, J., Yuan, L., Liu, Y., Chen, B., Gong, M., Xia, F., & Lou, X. (2023) · Advanced Science · doi:10.1002/advs.202207228 · Cited by 30
La Porta, C. A. M., & Zapperi, S. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.07.003 · Cited by 27
Cellular pharmacology of evofosfamide (TH-302): A critical re-evaluation of its bystander effects
Hong, C. R., Dickson, B. D., Jaiswal, J. K., Pruijn, F. B., Hunter, F. W., Hay, M. P., Hicks, K. O., & Wilson, W. R. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.08.027 · Cited by 33
Nanomaterial-Based Modulation of Tumor Microenvironments for Enhancing Chemo/Immunotherapy
Le, Q., Suh, J., & Oh, Y. (2019) · The AAPS Journal · doi:10.1208/s12248-019-0333-y · Cited by 31
Travelling under pressure - hypoxia and shear stress in the metastatic journey
Ildız, E. S., Gvozdenovic, A., Kovacs, W. J., & Aceto, N. (2023) · Clinical & Experimental Metastasis · doi:10.1007/s10585-023-10224-8 · Cited by 39
Tumor Hypoxia As an Enhancer of Inflammation-Mediated Metastasis: Emerging Therapeutic Strategies
DiGiacomo, J. W., & Gilkes, D. M. (2018) · Targeted Oncology · doi:10.1007/s11523-018-0555-4 · Cited by 31
Self-citationLang, T., Zheng, Z., Huang, X. Y., Liu, Y., Zhai, Y., Zhang, P., Li, Y., & Yin, Q. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202007402 · Cited by 30
Targeting the purinergic pathway in breast cancer and its therapeutic applications
de Araújo, J. B., Kerkhoff, V. V., Maciel, S. F. V. D. O., & Silva, D. T. D. R. E. (2021) · Purinergic Signalling · doi:10.1007/s11302-020-09760-9 · Cited by 36
“Hypoxic TME favors the expression of molecules related to tumor survival and progression [188].”
BackgroundHydrogel Models with Stiffness Gradients for Interrogating Pancreatic Cancer Cell Fate
Chang, C., & Lin, C. (2021) · Bioengineering · doi:10.3390/bioengineering8030037 · Cited by 31
“Additionally, the hypoxia created in the TME by the rapidly proliferating cancer cells and a stiffened matrix has been shown to not only facilitate cancer cell migration through Notch signaling and Snail-1 upregulation but also increase collagen deposition and MMP production [43].”
BackgroundChen, Y., Jin, L., Jiang, Z., Liu, S., & Feng, W. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.644426 · Cited by 34
Non-alcoholic steatohepatitis and risk of hepatocellular carcinoma
Rios, R. S., Zheng, K. I., & Zheng, M.-H. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001888 · Cited by 29
“upregulating HIF-2a [EPAS1] gene, which is a part of a family of genes of key importance to hypoxic environment response) which in turn, can increase its lethality, resistance to treatment and expanded metastasis regions.([69-74]) HIF-2a, due to its role in promoting disease progression in a subset of patients with bo…”
BackgroundKim, Y.-J., Zhao, Y., Myung, J. K., Yi, J. M., Kim, M., & Lee, S. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109996 · Cited by 31
Differential regulation and synthetic lethality of exclusive RB1 and CDKN2A mutations in lung cancer
Kim, N., Song, M., Kim, S., SEO, Y., Kim, Y., & Yoon, S. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3262 · Cited by 30
Chen, Y., Zhang, Y., Wang, J., Chen, N., Fang, W., Zhong, J., Liu, Y., Qin, R., Yu, X., Sun, Z. S., et al. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12491 · Cited by 29
“Hypoxia is a pathobiological hallmark of rapidly growing solid tumors, including NSCLC (Gilkes et al., 2014).”
BackgroundNguyen, T. D., Kadri, O. E., Sikavitsas, V. I., & Voronov, R. S. (2019) · Applied Sciences · doi:10.3390/app9112381 · Cited by 29
SHMT2 Promotes Gastric Cancer Development through Regulation of HIF1α/VEGF/STAT3 Signaling
Wang, W., Wang, M., Du, T., Hou, Z., You, S., Zhang, S., Ji, M., Xue, N., & Chen, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087150 · Cited by 32
Jia, L., Hong, Y., He, X., Zhou, Y., Ren, L., Du, H., Zhao, B., Qin, B., Yang, Z., & Gao, D. (2024) · Chinese Chemical Letters · doi:10.1016/j.cclet.2024.109957 · Cited by 29
Liu, Z., Liu, L., Lu, T., Wang, L., Li, Z., Jiao, D., & Han, X. (2021) · Journal of Oncology · doi:10.1155/2021/6664386 · Cited by 34
“MYC amplification improved the RUVBL2 expression, while the overexpression of RUVBL2 exhibited shorter RFS by regulating AKTand ERK/MAPK pathway in HCC [9].”
BackgroundWang, X., Kutschat, A. P., Yamada, M., Prokakis, E., Böttcher, P., Tanaka, K., Doki, Y., Hamdan, F. H., & Johnsen, S. A. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00751-w · Cited by 30
“2A), processes critical for cell migration [45, 46], as being key downstream targets of BRDT.”
BackgroundLi, W., Ding, Z., Wang, D., Li, C., Pan, Y., Zhao, Y., Zhao, H., Lu, T., Xu, R., Zhang, S., et al. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02041-4 · Cited by 30
“Extracellular matrix (ECM) and substrate constitute the first barrier of tumor metastasis, the major component of the ECM are fibrous proteins (such as collagens, elastins) and proteoglycans, which was activated aberrantly in the development of cancer [41].”
BackgroundMetabolic landscapes in sarcomas
MIALLOT, R., Galland, F., Millet, V., Blay, J., & Naquet, P. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01125-y · Cited by 35
Wu, H., Chu, Y., Sun, S., Li, G., Xu, S., Zhang, X., Jiang, Y., Gao, S., Wang, Q., Zhang, J., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.607142 · Cited by 30
Deep Learning Identification of Stiffness Markers in Breast Cancer
Sneider, A., Kiemen, A. L., Kim, J. H., Wu, P.-H., Habibi, M., White, M. J., Phillip, J. M., Gu, L., & Wirtz, D. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2022.121540 · Cited by 28
Self-citationRecent Advances on the Role of ATGL in Cancer
Zhang, R., Meng, J., Yang, S., Liu, W., Shi, L., Zeng, J., Chang, J., Liang, B., Liu, N., & Xing, D. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.944025 · Cited by 40
‘Two-faces’ of hyaluronan, a dynamic barometer of disease progression in tumor microenvironment
Liu, Y., Li, L., Wang, L., Lu, L., Li, Y., Huang, G., & Song, J. (2023) · Discover Oncology · doi:10.1007/s12672-023-00618-1 · Cited by 35
“motility, and play an important role in tumor metastasis [8].”
BackgroundMultifaceted ability of naturally occurring polyphenols against metastatic cancer
Zhou, Q. S., Bennett, L. L., & Zhou, S. (2016) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12546 · Cited by 29
Zhang, X., Liu, R., Shu, Q., Yuan, Q., Xing, G., & Gao, X. (2018) · Small · doi:10.1002/smll.201703684 · Cited by 29
Multicellular tumor spheroids: A convenient in vitro model for translational cancer research
Patel, T. C., & Jain, N. D. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123184 · Cited by 35
Cancer cell aggregate hypoxia visualized in vitro via biocompatible fiber sensors
Xue, R., Nelson, M. T., Teixeira, S. A., Viapiano, M. S., & Lannutti, J. J. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.10.055 · Cited by 29
Visualisation of newly synthesised collagen in vitro and in vivo
Oostendorp, C., Uijtdewilligen, P. J. E., Versteeg, E. M. M., Hafmans, T. G. M., van den Bogaard, E. H. J., de Jonge, P. K. J. D., Pirayesh, A., den Hoff, J. W. V., Ernst Reichmann, A., Daamen, W. F., et al. (2016) · Scientific Reports · doi:10.1038/srep18780 · Cited by 27
Marcucci, F., & Rumio, C. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00714 · Cited by 28
Dong, Q., Shi, L., Li, Y., Jiang, M., Sun, H. Q., Wang, B., Cheng, H., Zhang, Y., Shao, T., Shi, Y., et al. (2018) · BMC Genomics · doi:10.1186/s12864-018-5318-1 · Cited by 27
RhoB is regulated by hypoxia and modulates metastasis in breast cancer
Ju, J. A., Godet, I., DiGiacomo, J. W., & Gilkes, D. M. (2019) · Cancer Reports · doi:10.1002/cnr2.1164 · Cited by 33
“Rapid cancer cell proliferation, combined with structural and functional abnormalities in tumor blood vessels, results in regions within solid tumors that have reduced oxygen availability.(27) During this process, hypoxic cells obtain invasive and metastatic properties as well as resistance to chemotherapy and radiati…”
BackgroundSelf-citationMicrofluidic adhesion analysis of single glioma cells for evaluating the effect of drugs
Zhang, Q., Mao, S., Li, W., Huang, Q., Feng, S., Hong, Z., & Lin, J. (2020) · Science China Chemistry · doi:10.1007/s11426-020-9734-7 · Cited by 27
Stimulus-responsive gold nanotheranostic platforms for targeting the tumor microenvironment
Mandal, D., Paul, P., & Bhowmik, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821712-2.00003-7 · Cited by 28
Wozny, A., Gauthier, A., Alphonse, G., Malésys, C., Varoclier, V., Beuve, M., Brichart-Vernos, D., Magné, N., Vial, N., Ardail, D., et al. (2021) · Cancers · doi:10.3390/cancers13153833 · Cited by 29
Zhao, J., Peng, Y., Diaz‐Dussan, D., White, J., Duan, W., Kong, L., Narain, R., & Hao, X. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00518 · Cited by 27
Engineering nanomedicines to inhibit hypoxia-inducible Factor-1 for cancer therapy
Zhang, X., He, C., & Xiang, G. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.01.012 · Cited by 29
Choi, J., Chung, T., Rhee, H., Kim, Y., Jeon, Y., Yoo, J. E., Noh, S., Han, D. H., & Park, Y. N. (2018) · Gut and Liver · doi:10.5009/gnl17569 · Cited by 30
Shen, X., & Gates, K. S. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00036 · Cited by 304
Non‐viral gene delivery for cancer immunotherapy
Wang, W., Saeed, M., Zhou, Y., Yang, L., Wang, D., & Yu, H. (2019) · The Journal of Gene Medicine · doi:10.1002/jgm.3092 · Cited by 30
“The extracellular matrix in the tumor microenvironment acts as a biological barrier for efficient penetration of NPs in solid tumors and ultimately influences therapeutic performance.(58,59) However, hyaluronic acid (HA) is one of the major components of the extracellular matrix, which is overexpressed in various soli…”
BackgroundThe role of scaffolds in tissue engineering
Okamoto, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-08-102563-5.00002-2 · Cited by 31
Photocleavable Surfactant-Enabled Extracellular Matrix Proteomics
Knott, S. J., Brown, K. A., Josyer, H., Carr, A. V., Inman, D. R., Jin, S., Friedl, A., Ponik, S. M., & Ge, Y. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c03104 · Cited by 30
Roles of mitochondrial genetics in cancer metastasis
Welch, D. R., Foster, C., & Rigoutsos, I. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.07.004 · Cited by 28
MTHFD2-mediated redox homeostasis promotes gastric cancer progression under hypoxic conditions
Mo, H., Wang, R.-B., Ma, M., Zhang, Y., Li, X., Wen, W., Han, Y., & Tian, T. (2024) · Redox Report · doi:10.1080/13510002.2024.2345455 · Cited by 37
“In addition, numerous lines of evidence suggest that hypoxia contributes to the cancer stem cell phenotype, invasion, and resistance to chemo-and immunotherapies [49, 52].”
BackgroundYang, Y., Wu, T., Wang, Y., Luo, D., Zhao, Z., Sun, H., Zhang, M., Zhang, B., & Han, B. (2024) · Immunology · doi:10.1111/imm.13853 · Cited by 32
“Hypoxia is a typical hallmark of solid tumour proliferation and is associated with tumour angiogenesis, invasion, metastasis and recruitment of immune cells in the tumour microenvironment [7, 19, 20].”
Advances in nano drug delivery systems for enhanced efficacy of emodin in cancer therapy
Ai, Z., Liu, B., Chen, J., Zeng, X., Wang, K., Tao, C., Chen, J., Yang, L., Ding, Q., & Zhou, M. (2024) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2024.100314 · Cited by 43
“Notably, 90 % of cancer-related deaths are attributed to metastasis (Gilkes et al., 2014).”
Domura, R., Sasaki, R., Okamoto, M., Hirano, M., Kohda, K., Napiwocki, B. N., & Turng, L. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb00207f · Cited by 27
Identification of Interacting Stromal Axes in Triple-Negative Breast Cancer
Saleh, S. M. I., Bertos, N., Gruosso, T., Gigoux, M., Souleimanova, M., Zhao, H., Ömeroğlu, A., Hallett, M. T., & Park, M. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3427 · Cited by 28
Nanomedicine Revisited: Next Generation Therapies for Brain Cancer
Bhargav, A. G., Mondal, S. K., Garcia, C. A., Green, J. J., & Quiñones‐Hinojosa, A. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000118 · Cited by 32
Hypoxia Promotes Syndecan-3 Expression in the Tumor Microenvironment
Prieto‐Fernández, E., Egia‐Mendikute, L., Bosch, A., Río, A. G.-D., Jiménez-Lasheras, B., Antoñana-Vildosola, A., Lee, S. Y., & Palazón, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.586977 · Cited by 27
“Hypoxia also modulates the fate and function of different immune populations, including T cells and macrophages (33), and the organization of the ECM that influences their migration and infiltration (34).”
Background
Metadata
- Authors
- Gilkes, D. M., Semenza, G. L., & Wirtz, D.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Wirtz, Denis
- Venue
- Nature Reviews Cancer
- Published
- 2014-05-15
- Volume
- 14
- Issue
- 6
- Pages
- 430-439
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC4283800
- OpenAlex
- W2069518226
- Cited by
- 1,520
- References
- 209
- Citations by year
- 2026: 99 · 2025: 129 · 2024: 149 · 2023: 151 · 2022: 175 · 2021: 192 · 2020: 164 · 2019: 132 · 2018: 106 · 2017: 95 · 2016: 75 · 2015: 41 · 2014: 9
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (U54CA143868, R01CA174388, K99CA181352)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Keywords
- tumor hypoxia, extracellular matrix, tumour metastasis, tumor microenvironment, stromal cells, tumor cell motility, tumor cell proliferation
- MeSH terms
- Hypoxia, Extracellular Matrix, Humans, Neoplasm Metastasis, Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.